Pages that link to "Q40074127"
Jump to navigation
Jump to search
The following pages link to Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia (Q40074127):
Displaying 13 items.
- MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4 (Q24633718) (← links)
- The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells (Q27304392) (← links)
- Cpd-1 Null Mice Display a Subtle Neurological Phenotype (Q27320487) (← links)
- pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs (Q28476402) (← links)
- Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complex (Q28574246) (← links)
- Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells (Q34890054) (← links)
- Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients. (Q36998120) (← links)
- The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. (Q37347966) (← links)
- The Past, Present, and Future of Biomarkers: A Need for Molecular Beacons for the Clinical Management of Pancreatic Cancer (Q37939891) (← links)
- Molecular predictors of gemcitabine response in pancreatic cancer (Q39250668) (← links)
- Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas (Q39747039) (← links)
- PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis (Q42181561) (← links)
- ANP32A regulates histone H3 acetylation and promotes leukemogenesis. (Q52691502) (← links)